Put companies on watchlist
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München
ISIN: DE0008430026
WKN: 843002
Curious about what AI knows about Münchener Rück? Just one click more
More AI Integrations
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München · ISIN: DE0008430026 · EQS - adhoc news (22 News)
Country: Germany · Primary market: Germany · EQS NID: 2173634
23 July 2025 12:41PM

Supervisory Board decides on changes to the Board of Management


EQS-Ad-hoc: Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München / Key word(s): Personnel
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München: Supervisory Board decides on changes to the Board of Management

23-Jul-2025 / 12:41 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.


At its meeting today, Munich Reinsurance Company’s Supervisory Board decided on a change in leadership at Munich Re and further changes to the Board of Management.

Dr. Joachim Wenning (60), Chair of the Board of Management, after careful consideration has announced that for personal reasons he does not wish to continue in his role on the Board of Management beyond 31 December 2025. He instead has decided to retire upon completion of the Ambition 2025 strategy programme.

Dr. Christoph Jurecka (50) has been appointed to succeed him as Chair of the Board of Management, with effect from 1 January 2026. Dr. Jurecka has been with the Group since 2011, initially as a member of the Board of Management of ERGO Group AG. In 2019, he joined Munich Reinsurance Company’s Board of Management as Chief Financial Officer (CFO).

Moreover, the Supervisory Board has appointed Andrew Buchanan (47) to the Board of Management, with effect from 1 January 2026. He will succeed Christoph Jurecka as CFO of Munich Reinsurance Company. Originally from South Africa, Mr. Buchanan joined Munich Re in 2011 and has been CFO of the reinsurance field of business since 2017.

Furthermore, Robin Johnson (57) has been appointed to the Board of Management, with effect from 1 August 2025. He will assume the new role of Munich Reinsurance Company’s Chief Technology Officer (CTO). Mr. Johnson, originally from the United Kingdom, has been with the Group since 2017 as Chief Information Officer for the reinsurance field of business. In 2023, he assumed an additional role as CTO on the Board of Management of ERGO Group AG. Mr. Johnson is also Chair of the Board of Management of ERGO Technology & Services Management AG.

 




Contact:
Dr. Stefan Gehring
General Counsel & Group Compliance Officer


End of Inside Information

23-Jul-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München
Königinstraße 107
80802 München
Germany
Phone: +49(0) 89 3891-0
Fax: +49(0) 89 399 056
E-mail: shareholder@munichre.com
Internet: www.munichre.com
ISIN: DE0008430026, DE0008430026
WKN: 843002, 843002
Indices: DAX, EURO STOXX 50
Listed: Regulated Market in Frankfurt (Prime Standard), Munich; Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Stuttgart, Tradegate Exchange; Mailand
EQS News ID: 2173634

 
End of Announcement EQS News Service

2173634  23-Jul-2025 CET/CEST

Visual performance / price development - Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München
Smart analysis and research tools can be found here.
MIC: XETR
Power-Shortcuts

Muenchener Rueckversicherungs-Gesellschaft in Muenchen AG

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2025
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.